Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy

Sandahl, Mads; Sandahl, Kristian Juul; Marinovskij, Edvard; Nielsen, Tomas Frahm; Sørensen, Karina Dalsgaard; Borre, Michael; Ulhøi, Benedicte Parm; Pedersen, Birthe D.

doi:10.1016/j.euros.2022.05.002

Cited by 4 publications

(3 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…24 In this context, a study by Sandahl et al compared the diagnostic accuracy for prostate cancer after tissue sampling by manually operated in-bore MRI-targeted prostate biopsy (MO-MRGB) versus robot-assisted in-bore MRI-targeted prostate biopsy (RA-MRGB). 38 The authors noted that there was no significant difference in the diagnostic accuracy between the two (72 vs. 73%, 95% CI: –4 to 7%, p < 0.05) and raised some concerns over the cost-effectiveness. The same philosophy has been expanded and prototype models have been tested for a variety of procedures like lumbar spine injections, breast cancer, and prostate cancer.…”

Section: Robotic System Characteristicsmentioning

confidence: 97%

Innovations in Image-Guided Procedures: Unraveling Robot-Assisted Non-Hepatic Percutaneous Ablation

Chlorogiannis,

Charalampopoulos,

Bale

et al. 2024

Semin intervent Radiol

View full text Add to dashboard Cite

Interventional oncology is routinely tasked with the feat of tumor characterization or destruction, via image-guided biopsy and tumor ablation, which may pose difficulties due to challenging-to-reach structures, target complexity, and proximity to critical structures. Such procedures carry a risk-to-benefit ratio along with measurable radiation exposure. To streamline the complexity and inherent variability of these interventions, various systems, including table-, floor-, gantry-, and patient-mounted (semi-) automatic robotic aiming devices, have been developed to decrease human error and interoperator and intraoperator outcome variability. Their implementation in clinical practice holds promise for enhancing lesion targeting, increasing accuracy and technical success rates, reducing procedure duration and radiation exposure, enhancing standardization of the field, and ultimately improving patient outcomes. This narrative review collates evidence regarding robotic tools and their implementation in interventional oncology, focusing on clinical efficacy and safety for nonhepatic malignancies.

show abstract

Section: Robotic System Characteristicsmentioning

confidence: 97%

Innovations in Image-Guided Procedures: Unraveling Robot-Assisted Non-Hepatic Percutaneous Ablation

Chlorogiannis,

Charalampopoulos,

Bale

et al. 2024

Semin intervent Radiol

View full text Add to dashboard Cite

show abstract

“…During this procedure, special unmagnetized needles are guided to the target using T2‐weighted images 29 . In‐bore MRITB can be conducted using either manual or robot‐assisted needle‐guide systems 30,31 . The third method is MR/US image fusion, in which MRI and TRUS images are virtually fused in real time with dedicated software to guide biopsy.…”

Section: Mri/us Image‐fusion Biopsymentioning

confidence: 99%

“…29 In-bore MRITB can be conducted using either manual or robot-assisted needleguide systems. 30,31 The third method is MR/US image fusion, in which MRI and TRUS images are virtually fused in real time with dedicated software to guide biopsy. The effectiveness of MR/US fusion biopsy has been confirmed to be reliable and is becoming more widespread worldwide.…”

Section: Mri/us Image-fusion Biopsymentioning

confidence: 99%

Current magnetic resonance imaging‐based diagnostic strategies for prostate cancer

Inoue,

Shin

2023

Int J of Urology

View full text Add to dashboard Cite

Recent developments in multiparametric MRI and MRI‐targeted biopsy have made it possible to detect clinically significant cancers more accurately and efficiently than ever before. Furthermore, software that enables easy MRI/US image fusion has been developed and is already available on the market, and this has provided a tailwind for the spread of MRI‐based prostate cancer diagnostic strategies. Such precise diagnosis of prostate cancer localization is essential for highly accurate focal therapy. In addition, a recent large‐scale study applying MRI to community screening for prostate cancer has reported its usefulness. By contrast, concerns about overdiagnosis and overtreatment, the existence of inter‐reader variability in MRI diagnosis, and issues with current MRI‐targeted biopsy have emerged. In this article, we review the development of multiparametric MRI and MRI‐targeted biopsy to date and the current issues and discuss future directions.

show abstract

Results from the PRIMA Trial: Comparison of the STHLM3 Test and Prostate-specific Antigen in General Practice for Detection of Prostate Cancer in a Biopsy-naïve Population

Fredsøe,

Sandahl,

Vedsted

et al. 2023

European Urology Oncology

View full text Add to dashboard Cite

Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy

Cited by 4 publications

References 23 publications

Innovations in Image-Guided Procedures: Unraveling Robot-Assisted Non-Hepatic Percutaneous Ablation

Innovations in Image-Guided Procedures: Unraveling Robot-Assisted Non-Hepatic Percutaneous Ablation

Current magnetic resonance imaging‐based diagnostic strategies for prostate cancer

Results from the PRIMA Trial: Comparison of the STHLM3 Test and Prostate-specific Antigen in General Practice for Detection of Prostate Cancer in a Biopsy-naïve Population

Contact Info

Product

Resources

About